Northstar

NorthStar Healthcare Announces Virtual-Only Format for 2020 Annual Meeting of Stockholders

Retrieved on: 
Thursday, June 4, 2020

NEW YORK, June 4, 2020 /PRNewswire/ -- NorthStar Healthcare Income, Inc. ("NorthStar Healthcare") announced today that its 2020 annual meeting of stockholders (the "Annual Meeting") will be held as a virtual-only meeting at https://viewproxy.com/northstar/2020/ on the previously announced date and time of Thursday, June 18, 2020 at 9:00 a.m. Eastern Time in light of the public health threat caused by the COVID-19pandemic.

Key Points: 
  • NEW YORK, June 4, 2020 /PRNewswire/ -- NorthStar Healthcare Income, Inc. ("NorthStar Healthcare") announced today that its 2020 annual meeting of stockholders (the "Annual Meeting") will be held as a virtual-only meeting at https://viewproxy.com/northstar/2020/ on the previously announced date and time of Thursday, June 18, 2020 at 9:00 a.m. Eastern Time in light of the public health threat caused by the COVID-19pandemic.
  • NorthStar Healthcare intends to return to anin-personformat for future annual meetings of stockholders.
  • Technical assistance will be available for stockholders encountering any difficulties registering or accessing the virtual Annual Meeting.
  • Whether or not stockholders plan to participate in the virtual-only Annual Meeting, NorthStar Healthcare urges stockholders to authorize a proxy to vote in advance of the Annual Meeting by one of the methods described in the proxy materials.

Tara Bing Joins NorthStar Life Services as Director of Client Services

Retrieved on: 
Tuesday, May 19, 2020

NorthStar Life Services , LLC, a full-service life settlement advisory firm that assists institutional and private investors with each stage of the life settlement investment cycle, has named industry veteran Tara Bing as director of client services.

Key Points: 
  • NorthStar Life Services , LLC, a full-service life settlement advisory firm that assists institutional and private investors with each stage of the life settlement investment cycle, has named industry veteran Tara Bing as director of client services.
  • Tara is a highly regarded professional in the life settlement space and has a depth and breadth of experience that is truly unique, said John McFarland, chief executive officer of NorthStar Life Services.
  • Bing has worked in the life settlement industry for nearly 17 years, most recently as a client services manager and director of operations at AVS Group, LLC.
  • NorthStar Life Services, LLC offers a full range of premier services to institutional and private investors in life insurance policies, providing assistance at each stage of the life settlement investment cycle.

Protect from Home: NorthStar Home Goes to Remote Customer Engagement with 8x8

Retrieved on: 
Friday, April 3, 2020

NorthStar Home, founded in 2000, is consistently reviewed as one of the premier home security service providers in the U.S.

Key Points: 
  • NorthStar Home, founded in 2000, is consistently reviewed as one of the premier home security service providers in the U.S.
  • NorthStar Homes mission is to provide our customers with security and peace of mind through quality products and superior service.
  • 8x8 Video Meetings also enhanced team communication and collaboration amongst the remote workforce, and during agent coaching as well.
  • 8x8 and 8x8 X Series are trademarks of 8x8, Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20200403005079/en/

John McFarland Acquires Servicing Business of NorthStar Life Services, LLC

Retrieved on: 
Friday, March 20, 2020

NorthStar Life Services , LLC, a full-service life settlement advisory firm that assists institutional and private investors with each stage of the life settlement investment cycle, has been acquired by John McFarland, the companys chief executive officer since 2016.

Key Points: 
  • NorthStar Life Services , LLC, a full-service life settlement advisory firm that assists institutional and private investors with each stage of the life settlement investment cycle, has been acquired by John McFarland, the companys chief executive officer since 2016.
  • McFarland will continue to advise North Channel Bank on business development opportunities in the U.S. life settlement market and NorthStar will continue to serve as North Channel Banks preferred provider for life settlement portfolio management services.
  • NorthStar has developed a proprietary technology platform that supports the life settlement transaction advisory, due diligence and portfolio servicing, and portfolio management services it provides to life settlement investors.
  • NorthStar Life Services, LLC offers a full range of premier services to institutional and private investors in life insurance policies, providing assistance at each stage of the life settlement investment cycle.

Northstar Meetings Group Launches Industry-First Convention Cities Index

Retrieved on: 
Monday, March 16, 2020

SECAUCUS, N.J., March 16, 2020 /PRNewswire/ -- Northstar Meetings Group today launched the NMG Convention Cities Index (CCi), a first-in-class study that names the best destinations for the world's largest meetings and events.

Key Points: 
  • SECAUCUS, N.J., March 16, 2020 /PRNewswire/ -- Northstar Meetings Group today launched the NMG Convention Cities Index (CCi), a first-in-class study that names the best destinations for the world's largest meetings and events.
  • The CCi rankings reveal the top 25 global convention cities, as well as the top 25 U.S. cities.
  • The top five U.S. convention cities include: 1) Las Vegas, 2) Orlando, 3) Atlanta, 4) San Antonio, and 5) Indianapolis.
  • Northstar Meetings Group also produces the annual Stella Awards , recognizing organizations around the globe that consistently deliver quality service and innovation to meeting and event professionals.

Americans Turn Away from Public Transit as Direct Result of COVID-19

Retrieved on: 
Wednesday, March 11, 2020

Based on a Northstar public opinion poll among n=1000 Americans, which found that 48% feel that riding public transit poses a high health risk due to the virus.

Key Points: 
  • Based on a Northstar public opinion poll among n=1000 Americans, which found that 48% feel that riding public transit poses a high health risk due to the virus.
  • More specifically, between 30-40% of Americans report decreased usage of public transportation (subways, buses and light rail) as a direct result of COVID-19.
  • "People's movement away from public transit is likely to have long-term consequences," says Jennifer Yellin, SVP and co-lead of Northstar's Transportation Practice.
  • "The implications include lost revenue for public transit authorities, which is ultimately used to upgrade and maintain systems.

The global lead-acid battery market was valued at $39

Retrieved on: 
Monday, March 9, 2020

LeadAcid Battery Market by Product (SLI, Stationary, and Motive), Construction Method (Flooded and VRLA), and Application (Automotive, UPS, Telecom, and Others): Global Opportunity Analysis and Industry Forecast, 20192026

Key Points: 
  • LeadAcid Battery Market by Product (SLI, Stationary, and Motive), Construction Method (Flooded and VRLA), and Application (Automotive, UPS, Telecom, and Others): Global Opportunity Analysis and Industry Forecast, 20192026
    The global leadacid battery market was valued at $39.
  • As a result, the global leadacid battery market is growing at a stable pace across the globe.
  • The global leadacid battery market is segmented on the basis of product, construction method, application, and region.
  • The major player studied and profiled in the global leadacid battery market are EnerSys, Exide Industries, Crown Battery, East Penn, HOPPECKE, NorthStar, Hitachi Chemical, Teledyne Technologies, Hankook AltasBX, and C&D Technologies.

NorthStar Medical Technologies Expands Portfolio with Exclusive, Worldwide Licensing of Investigational Fibrin-targeted Cardiac Diagnostic Imaging Agent

Retrieved on: 
Tuesday, March 3, 2020

Under the agreement, NorthStar has licensed exclusive rights to a fibrin-targeted diagnostic imaging agent for cardiac imaging.

Key Points: 
  • Under the agreement, NorthStar has licensed exclusive rights to a fibrin-targeted diagnostic imaging agent for cardiac imaging.
  • FibroScint is a unique diagnostic agent and an ideal addition to our portfolio which complements the commercially available RadioGenix System (technetium Tc 99m generator).
  • NorthStar Medical Radioisotopes is a global innovator in the production and distribution of radioisotopes used for medical imaging and therapeutic purposes.
  • Founded in 2006 and based in Beloit, Wis., NorthStar Medical Technologies is the parent organization of several wholly-owned subsidiaries, including NorthStar Medical Radioisotopes, LLC.

FDA Approves Additional Molybdenum-99 (Mo-99) Filling Lines at NorthStar Medical Radioisotopes’ Columbia, Mo. Facility

Retrieved on: 
Tuesday, February 18, 2020

NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved the addition of two molybdenum-99 (Mo-99) filling lines at its facility in Columbia, Mo.

Key Points: 
  • NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved the addition of two molybdenum-99 (Mo-99) filling lines at its facility in Columbia, Mo.
  • facility means an immediate increase in Mo-99 production efficiencies in Columbia, said Stephen Merrick, President and Chief Executive Officer of NorthStar.
  • To report SUSPECTED ADVERSE REACTIONS, contact NorthStar Medical Radioisotopes, LLC at 1-844-438-6659; or FDA at 1-800-332-1088 or www.fda.gov/medwatch .
  • Founded in 2006 and based in Beloit, Wis., NorthStar Medical Radioisotopes, LLC is a wholly-owned subsidiary of NorthStar Medical Technologies, LLC.

NorthStar Medical Technologies Signs Letter of Intent with Clarity Pharmaceuticals to Supply Therapeutic Radioisotope Copper-67 (Cu-67)

Retrieved on: 
Tuesday, February 11, 2020

Under terms of the agreement, NorthStar will provide Clarity Pharmaceuticals with Cu-67, a beta-emitting radioisotope with potential applications as a targeted radiopharmaceutical for treatment of a range of cancers.

Key Points: 
  • Under terms of the agreement, NorthStar will provide Clarity Pharmaceuticals with Cu-67, a beta-emitting radioisotope with potential applications as a targeted radiopharmaceutical for treatment of a range of cancers.
  • NorthStar is committed to developing and commercializing innovative technologies for Cu-67 radioisotope production to advance medical research and meet patient needs, said Stephen Merrick, President and Chief Executive Officer of NorthStar Medical Technologies.
  • NorthStar Medical Radioisotopes is a global innovator in the production and distribution of radioisotopes used for medical imaging and therapeutic purposes.
  • Founded in 2006 and based in Beloit, Wis., NorthStar Medical Technologies is the parent organization of several wholly-owned subsidiaries, including NorthStar Medical Radioisotopes, LLC.